1. Home
  2. GCTK vs BMRA Comparison

GCTK vs BMRA Comparison

Compare GCTK & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GCTK
  • BMRA
  • Stock Information
  • Founded
  • GCTK 2001
  • BMRA 1971
  • Country
  • GCTK United States
  • BMRA United States
  • Employees
  • GCTK N/A
  • BMRA N/A
  • Industry
  • GCTK Medical/Dental Instruments
  • BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • GCTK Health Care
  • BMRA Health Care
  • Exchange
  • GCTK Nasdaq
  • BMRA Nasdaq
  • Market Cap
  • GCTK 7.1M
  • BMRA 7.4M
  • IPO Year
  • GCTK N/A
  • BMRA N/A
  • Fundamental
  • Price
  • GCTK $2.17
  • BMRA $0.34
  • Analyst Decision
  • GCTK
  • BMRA
  • Analyst Count
  • GCTK 0
  • BMRA 0
  • Target Price
  • GCTK N/A
  • BMRA N/A
  • AVG Volume (30 Days)
  • GCTK 10.0K
  • BMRA 68.9K
  • Earning Date
  • GCTK 11-02-2024
  • BMRA 10-15-2024
  • Dividend Yield
  • GCTK N/A
  • BMRA N/A
  • EPS Growth
  • GCTK N/A
  • BMRA N/A
  • EPS
  • GCTK N/A
  • BMRA N/A
  • Revenue
  • GCTK N/A
  • BMRA $5,509,000.00
  • Revenue This Year
  • GCTK N/A
  • BMRA N/A
  • Revenue Next Year
  • GCTK N/A
  • BMRA N/A
  • P/E Ratio
  • GCTK N/A
  • BMRA N/A
  • Revenue Growth
  • GCTK N/A
  • BMRA 1.74
  • 52 Week Low
  • GCTK $0.67
  • BMRA $0.24
  • 52 Week High
  • GCTK $4.95
  • BMRA $2.13
  • Technical
  • Relative Strength Index (RSI)
  • GCTK 41.99
  • BMRA 50.80
  • Support Level
  • GCTK $2.11
  • BMRA $0.28
  • Resistance Level
  • GCTK $2.29
  • BMRA $0.36
  • Average True Range (ATR)
  • GCTK 0.10
  • BMRA 0.04
  • MACD
  • GCTK -0.02
  • BMRA 0.00
  • Stochastic Oscillator
  • GCTK 50.49
  • BMRA 65.00

About GCTK GlucoTrack Inc.

GlucoTrack Inc is a medical device company. It focuses on the design, development, and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. The company has developed a non-invasive glucose monitor, the GlucoTrack model DF-F glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings without the pain, inconvenience, and difficulty of conventional spot finger stick devices. It has completed a feasibility study successfully demonstrating that a minimum two-year implant life is highly probable with the sensor design. They have also initiated an animal study with an initial prototype system that has thus far demonstrated a simple implant procedure and good functionality.

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.

Share on Social Networks: